![Xiao Hui Ji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 449 881 $ al 31/01/2026
Xiao Hui Ji is the founder of Elpiscience Biopharma Ltd., serving as Chairman & Chief Executive Officer since 2017.
Dr. Ji is the founder of Elpiscience Biopharmaceuticals, Inc., serving as Chairman & Chief Executive Officer since 2017.
Dr. Ji was the founder of PharmaLegacy Laboratories (Shanghai) Co., Ltd., serving as Chief Executive Officer from 2008 to 2012.
Dr. Ji is currently an Independent Director at Legend Biotech Corp.
since 2020.
Former positions include Director at The BayHelix Group from 2008 to 2013, Vice President-Business Development at Roche Holding AG from 2013 to 2016, and Partner at LAV Management Co., Ltd. from 2017 to 2020.
Education includes an MBA from The University of Chicago, a doctorate from The University of Sheffield, and a doctorate from China Medical University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
LEGEND BIOTECH CORP. 0,02 % | 11/03/2025 | 51.415 ( 0,02 % ) | 449 881 $ | 31/01/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Director/Miembro de la Junta | 01/05/2020 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Develops cutting-edge immunotherapies to fight cancer | Director Ejecutivo | 01/06/2017 |
Elpiscience Biopharmaceuticals, Inc.
 Elpiscience Biopharmaceuticals, Inc. Functions as an investment holding company whose subsidiaries operates clinical-stage biopharmaceutical company that develops immunotherapies for cancer patients | Director Ejecutivo | 01/06/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Corporate Officer/Principal | 01/05/2020 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/12/2016 |
The BayHelix Group | Director/Miembro de la Junta | 01/01/2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology and pharmacodynamics evaluation services | Director Ejecutivo | 01/01/2012 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Roche Holding AG
 Roche Holding AG Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sheffield
 The University of Sheffield Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Medical University
 China Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV invests in companies located in China and the United States. The firm targets companies operating in the fields of biopharmaceuticals, human therapeutics, medical devices and diagnostics. It provides financing for seed, early and later stage capital requirements. | Finance |
The BayHelix Group | |
Legend Biotech Corp.
 Legend Biotech Corp. Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | |
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Develops cutting-edge immunotherapies to fight cancer | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Operates as a biopharmaceutical research and development company that focuses on preclinical pharmacology and pharmacodynamics evaluation services | |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. Functions as an investment holding company whose subsidiaries operates clinical-stage biopharmaceutical company that develops immunotherapies for cancer patients |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
MarketScreener is also available in this country: United States.
Switch edition
